Assessing the risk of a major adverse cardiac event in patients with chest pain
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 14, 2016
Grant Date -
Apr 25, 2013
app pub date -
Dec 7, 2012
filing date -
Oct 22, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods for characterizing the near term risk of experiencing a major adverse cardiac event in a patient presenting to an Emergency Department with chest pain are provided. In one embodiment the method comprises determining the level of myeloperoxidase (MPO) activity and/or mass in a bodily sample obtained from the patient. Levels of MPO activity or MPO mass in bodily samples from the test subject are then compared to a control value in comparable bodily samples obtained from a control population. Such comparison can also be used to determine the near term treatment of the patient.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully